Forbes April 19, 2024
Arianna Johnson

Topline

The American College of Physicians issued new guidelines for Type 2 diabetes treatment, which for the first time recommends the use of GLP-1s and another class of diabetes drugs called SGLT-2s alongside metformin, though this may exacerbate the ongoing drug shortages of several GLP-1s.

Key Facts

Will This Affect The Supply Of Glp-1s?

Some GLP-1 medications are already in a shortage due to high demand. Though all doses of diabetes drug Ozempic are available, all doses of Nordisk’s weight loss drug Wegovy are in a shortage except for its highest dose, 2.4 milligrams. Nordisk hasn’t provided a timeframe for when the supply will improve. Nordisk told Forbes it will gradually increase supply of all doses of Wegovy throughout the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Physician, Primary care, Provider
Related Articles:
California Sets 15% Goal for Primary Care Spending by 2034
Lessons from Forward Health: How direct primary care is the future of health care
5 objectives for achieving high-quality primary care at the state level
Are telehealth visits for pediatric primary care associated with higher rates of health care utilization?
70% of Americans want primary care providers to address mental health

Share This Article